| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/MP.2013.171 |
| P698 | PubMed publication ID | 24393807 |
| P2093 | author name string | S K Chung | |
| A C K Law | |||
| W K Jo | |||
| P2860 | cites work | Tripartite synapses: astrocytes process and control synaptic information | Q22337308 |
| Astrogliosis in CNS pathologies: is there a role for microglia? | Q23911551 | ||
| Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins | Q24292994 | ||
| RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction | Q24315809 | ||
| Endothelin-1 overexpression leads to further water accumulation and brain edema after middle cerebral artery occlusion via aquaporin 4 expression in astrocytic end-feet | Q48939356 | ||
| The effects of amyloid-β42 oligomer on the proliferation and activation of astrocytes in vitro | Q48939579 | ||
| Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease | Q48940326 | ||
| Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains | Q49112901 | ||
| Ischemia-induced apoptosis in primary cultures of astrocytes. | Q51064571 | ||
| Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences | Q51903055 | ||
| Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia. | Q51905657 | ||
| Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression. | Q52552907 | ||
| Amyloid-beta peptides are cytotoxic to oligodendrocytes. | Q53239840 | ||
| Expression and distribution of beta amyloid precursor protein and beta amyloid peptide in reactive astrocytes after transient middle cerebral artery occlusion. | Q53243101 | ||
| Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. | Q53248798 | ||
| Synapse Loss and Gliosis in the Molecular Layer of the Cerebral Cortex in Alzheimer's Disease and in Frontal Lobe Degeneration | Q53311348 | ||
| Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. | Q53343797 | ||
| Cerebral ischemia and Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus. | Q53390971 | ||
| Endothelins stimulate the expression of neurotrophin-3 in rat brain and rat cultured astrocytes. | Q54641241 | ||
| Protective Role of Reactive Astrocytes in Brain Ischemia | Q57779641 | ||
| An Investigation into the Formation of Annular Aggregates of Human Islet Amyloid Polypeptide on Tantalum Oxide Surfaces | Q61758890 | ||
| Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct | Q70325938 | ||
| Glial expression of the beta-amyloid precursor protein (APP) in global ischemia | Q72333929 | ||
| The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain | Q74290658 | ||
| Impact of aquaporin-4 channels on K+ buffering and gap junction coupling in the hippocampus | Q83739626 | ||
| Endothelin-1 protects astrocytes from hypoxic/ischemic injury | Q43548097 | ||
| The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation | Q43718629 | ||
| One year follow up in ischemic brain injury and the role of Alzheimer factors. | Q43722042 | ||
| Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers | Q44026421 | ||
| Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains | Q44410484 | ||
| RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain | Q44479225 | ||
| RAGE expression is up-regulated in human cerebral ischemia and pMCAO rats | Q44878768 | ||
| ABri peptide associated with familial British dementia forms annular and ring-like protofibrillar structures | Q44927868 | ||
| Endothelial endothelin-1 over-expression using receptor tyrosine kinase tie-1 promoter leads to more severe vascular permeability and blood brain barrier breakdown after transient middle cerebral artery occlusion | Q46115630 | ||
| Essential protective roles of reactive astrocytes in traumatic brain injury | Q46428573 | ||
| RAGE recycles at the plasma membrane in S100B secretory vesicles and promotes Schwann cells morphological changes | Q46615252 | ||
| Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease. | Q46649371 | ||
| Loss of astrocytic domain organization in the epileptic brain. | Q46681558 | ||
| Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. | Q46729659 | ||
| Endothelin-1 is elevated in Alzheimer's disease brain microvessels and is neuroprotective | Q48125668 | ||
| Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 | ||
| Endothelin-1-like immunoreactivity is expressed in human reactive astrocytes | Q48254984 | ||
| Endothelin-1 enhances cell migration via matrix metalloproteinase-9 up-regulation in brain astrocytes | Q48258310 | ||
| Autocrine S100B effects on astrocytes are mediated via RAGE. | Q48297630 | ||
| Diversity among reactive astrocytes: proximal reactive astrocytes in lacerated spinal cord preferentially react with monoclonal antibody J1-31. | Q48355417 | ||
| beta-Amyloid precursor protein and ss-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion: effect of age. | Q48384381 | ||
| Local potassium signaling couples neuronal activity to vasodilation in the brain. | Q48407816 | ||
| Astroglial expression of the beta-amyloid in ischemia-reperfusion brain injury | Q48426714 | ||
| Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways | Q48637349 | ||
| RAGE mediates vascular injury and inflammation after global cerebral ischemia | Q48745361 | ||
| Classification and subtypes of vascular dementia | Q48763059 | ||
| Role of endothelin-1 in astrocyte responses after acute brain damage | Q48764532 | ||
| Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. | Q48771406 | ||
| Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease | Q48830095 | ||
| Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains | Q48930597 | ||
| Vascular dementia | Q24629003 | ||
| Astrocytes: biology and pathology | Q27490746 | ||
| Astrocyte glutamate transport: review of properties, regulation, and physiological functions | Q28138001 | ||
| Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation | Q28174277 | ||
| Reactive astrocytes protect tissue and preserve function after spinal cord injury | Q28248202 | ||
| Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture | Q28297639 | ||
| The mystery and magic of glia: a perspective on their roles in health and disease | Q28300305 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease | Q29617285 | ||
| Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains | Q29619208 | ||
| A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
| Amyloid Beta Annular Protofibrils in Cell Processes and Synapses Accumulate with Aging and Alzheimer-Associated Genetic Modification | Q30157432 | ||
| Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer | Q30157440 | ||
| Structural and quantitative analysis of astrocytes in the mouse hippocampus | Q31097047 | ||
| Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent | Q31123558 | ||
| Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies | Q33243260 | ||
| Cerebral blood flow in ischemic vascular dementia and Alzheimer's disease, measured by arterial spin-labeling magnetic resonance imaging | Q33573552 | ||
| Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years | Q33600226 | ||
| Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor | Q33688695 | ||
| Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease | Q33782706 | ||
| Calcium ions promote formation of amyloid β-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease | Q33862507 | ||
| Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice | Q33867506 | ||
| Progress in Alzheimer's disease | Q33943357 | ||
| Astrocyte-endothelial interactions and blood-brain barrier permeability | Q33960608 | ||
| The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia | Q34402033 | ||
| Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target? | Q34407469 | ||
| Astrocyte activation and reactive gliosis | Q34413317 | ||
| Astrocyte-mediated control of cerebral blood flow | Q34481040 | ||
| Mixed dementia: emerging concepts and therapeutic implications | Q34553430 | ||
| The epidemiology of the dementias: an update | Q34634824 | ||
| Mixed dementia: epidemiology, diagnosis, and treatment | Q34775417 | ||
| Synaptic modulation by astrocytes via Ca2+-dependent glutamate release. | Q34775774 | ||
| Regulation of amyloid beta-peptide levels by enzymatic degradation. | Q35006810 | ||
| Vascular disorder in Alzheimer's disease: role in pathogenesis of dementia and therapeutic targets | Q35009752 | ||
| Dysregulation of Ca2+ signaling in astrocytes from mice lacking amyloid precursor protein | Q35055580 | ||
| Inflammatory neurodegeneration and mechanisms of microglial killing of neurons | Q37701325 | ||
| Death and survival of neuronal and astrocytic cells in ischemic brain injury: a role of autophagy | Q37729790 | ||
| The interdependence of endothelin-1 and calcium: a review. | Q37775995 | ||
| Management of Mixed Dementia | Q37784483 | ||
| Alzheimer disease: update on basic mechanisms | Q37798384 | ||
| Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. | Q37892690 | ||
| Oxidative stress and β-amyloid protein in Alzheimer's disease | Q37928994 | ||
| Ionic transporter activity in astrocytes, microglia, and oligodendrocytes during brain ischemia | Q38095337 | ||
| Emerging roles of astrocytes in neural circuit development | Q38099738 | ||
| Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer's disease. | Q38112107 | ||
| RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model. | Q38355436 | ||
| Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells. | Q39462209 | ||
| RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease | Q39638245 | ||
| Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation | Q40170530 | ||
| The Role of Cerebral Microvessel Endothelium in Regulation of Cerebral Blood Flow Through Production of Endothelin-1 | Q41851787 | ||
| Neuron Specific Toxicity of Oligomeric Amyloid-β: Role for JUN-Kinase and Oxidative Stress | Q42262790 | ||
| Regulation of glial inflammatory mediators synthesis: possible role of endothelins | Q42442751 | ||
| ETA and ETB receptor antagonists synergistically increase extracellular endothelin-1 levels in primary rat astrocyte cultures. | Q42452751 | ||
| Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading | Q42471502 | ||
| S100B alters neuronal survival and dendrite extension via RAGE-mediated NF-κB signaling. | Q42483466 | ||
| The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes. | Q42497706 | ||
| Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins | Q43026196 | ||
| Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism | Q43519452 | ||
| Amyloid-β annular protofibrils evade fibrillar fate in Alzheimer disease brain | Q35063033 | ||
| Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. | Q35076662 | ||
| Longitudinal patterns of β-amyloid deposition in nondemented older adults | Q35104862 | ||
| Neurobiology of vascular dementia | Q35176496 | ||
| Receptor for advanced glycation end products (RAGE) prevents endothelial cell membrane resealing and regulates F-actin remodeling in a beta-catenin-dependent manner | Q35266372 | ||
| Single-channel Ca(2+) imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology | Q35503824 | ||
| The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis | Q35549855 | ||
| Cerebrovascular lesions induce transient β-amyloid deposition | Q35606745 | ||
| Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS | Q35677251 | ||
| Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection | Q35707254 | ||
| Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain | Q35764562 | ||
| Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury | Q35768729 | ||
| Astrocyte intermediate filaments in CNS pathologies and regeneration. | Q35923584 | ||
| Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme | Q36016766 | ||
| Microglia as a potential bridge between the amyloid beta-peptide and tau. | Q36024909 | ||
| Astrocytes in cerebral ischemic injury: morphological and general considerations | Q36104657 | ||
| The HMGB1 receptor RAGE mediates ischemic brain damage | Q36134557 | ||
| Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway | Q36321788 | ||
| Genomic analysis of reactive astrogliosis | Q36344611 | ||
| Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis | Q36375901 | ||
| Heterogeneity of astrocytic form and function | Q36422908 | ||
| Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors | Q36457613 | ||
| Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats | Q36735367 | ||
| Astroglia in neurological diseases | Q36819902 | ||
| Vascular cognitive deterioration and stroke | Q36986449 | ||
| Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury | Q37058141 | ||
| Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia | Q37077638 | ||
| Neurovascular signalling defects in neurodegeneration | Q37078102 | ||
| Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway | Q37226465 | ||
| Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta. | Q37257169 | ||
| Vascular factors in diabetes and Alzheimer's disease | Q37455870 | ||
| RAGE: the beneficial and deleterious effects by diverse mechanisms of actions | Q37599419 | ||
| Alzheimer's disease and endothelial dysfunction | Q37617130 | ||
| Alzheimer's mechanisms in ischemic brain degeneration | Q37640009 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| astrocyte | Q502961 | ||
| P304 | page(s) | 159-167 | |
| P577 | publication date | 2014-01-07 | |
| P1433 | published in | Molecular Psychiatry | Q6895973 |
| P1476 | title | The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders | |
| P478 | volume | 19 |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q48148540 | Astrocyte and Alzheimer's disease |
| Q48329233 | Astrocyte-derived lipocalin-2 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia |
| Q93063652 | Astrocytes are direct cellular targets of lithium treatment: novel roles for lysyl oxidase and peroxisome-proliferator activated receptor-γ as astroglial targets of lithium |
| Q38794680 | Astrocytes contribute to Aβ-induced blood-brain barrier damage through activation of endothelial MMP9. |
| Q95836632 | Circulating asymmetric dimethylarginine and cognitive decline: A four-year follow up study of the 1936 Aberdeen Birth Cohort |
| Q41774030 | Cocaine-Mediated Autophagy in Astrocytes Involves Sigma 1 Receptor, PI3K, mTOR, Atg5/7, Beclin-1 and Induces Type II Programed Cell Death |
| Q26798929 | Glia in the cytokine-mediated onset of depression: fine tuning the immune response |
| Q27023315 | Oxidized cholesterol as the driving force behind the development of Alzheimer's disease |
| Q36267383 | Selective astrocytic endothelin-1 overexpression contributes to dementia associated with ischemic stroke by exaggerating astrocyte-derived amyloid secretion. |
| Q26781639 | Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders |
| Q38785505 | The 5-Lipoxygenase as modulator of Alzheimer's γ-secretase and therapeutic target |
| Q26999358 | The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype |
| Q38278661 | The role of glia in stress: polyamines and brain disorders |
| Q36236937 | Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.